Global Respiratory Inhalers Market

Report ID : 1288 | Published : 2022-07-04 | Pages: | Format: PDF/EXCEL

The Global Respiratory Inhalers Market is estimated to reach over USD 61.29 billion by 2030, exhibiting a CAGR of 6.7% during the forecast period 

Respiratory inhalers are devices that are used to inhale medications that are an important part of the treatment for chronic lung diseases. Dry powder inhalers, metered-dose inhalers (MDIs), nebulizers, and soft mist inhalers are just a few of the products that deliver medicine directly to the airways. The rising prevalence of respiratory disorders has necessitated innovation in the production of respiratory inhalers. The demand for greater precision in drug delivery is allowing for greater adoption of Respiratory Inhaler Devices, particularly among asthma and chronic obstructive pulmonary disease patients (COPD). Inhalers are also being used by the growing geriatric population, who have lower immunity to chronic and pulmonary diseases. Respiratory inhalers include complimentary spacers or holding chamber devices to reduce deposition in the mouth and throat. The proposed shift to home healthcare is expected to boost the respiratory product market even further.

Moreover, the rise in air pollution levels around the world as a result of wildfires in forests, an increase in the number of vehicles, and an increase in the number of factories are the primary factors fueling the growth of the respiratory inhalers market. Increased use of fluoroscopy in pain management will also ensure rapid industry growth during the forecast period. Rapid technological development, as well as various initiatives, are undertaken by governments around the world to combat respiratory diseases by raising awareness about the symptoms and making new treatments more readily available, are providing growth opportunities for the market over the forecast period.

Market Segmentation:

The global respiratory inhalers market is segmented based on products, patients, Technology, and end-users. Based on products, the market is categorized as metered dosage, dry powder inhalers, nebulizers, compressed air nebulizers, ultrasonic nebulizers, and mesh nebulizers. The other patient segment includes adults and pediatrics. By Technology, the market is categorized into manually operated inhaler devices and digitally used inhaler devices. The other end-users segment includes hospital pharmacies, retail, and online.

Based on Technology, the digitally operated inhaler devices segment is accounted as a significant contributor to the global respiratory inhalers market.

The digitally operated inhaler devices category is expected to hold a major share in the global respiratory inhalers market in 2021. This is attributed to the technological advancements in respiratory inhalers. Interactive digital inhalers with advanced sensors and Artificial Intelligence (AI) Technology are being rolled out to help users manage their illnesses by providing guided instructions and recording user data. The integration of conventional digital inhalers and AI-enabled machine learning algorithms ensures that patients receive timed instructions and audio-visual signals to properly use the inhaler and take the prescribed medication regularly to avoid asthma attacks. In addition to asthma, an AI-enabled drug delivery mechanism has enormous potential in the treatment of COPD and other pulmonary ailments. The U.S. is the most influential regional market for the digital segment, accounting for 42.5% of the global sales in 2020.

The hospital Pharmacies segment recorded growth at a rapid rate

Due to rising awareness of technical improvements in inhaler devices, the hospital pharmacies sector of the worldwide respiratory inhalers market is anticipated to expand quickly. Rapid expansions in the healthcare infrastructure and improved access to healthcare services are anticipated to be key drivers of the growth of the hospital pharmacies market in emerging economies over the course of the forecast period, as will an increase in public-private partnerships to improve access to healthcare services.

In the region, the North American respiratory inhalers market holds a significant revenue share.

The North American respiratory inhalers market is expected to register the highest market share in terms of revenue over the forecast period. An increase in number of asthma cases, as well as the presence of well-known players, are expected to drive the growth of the respiratory inhalers market in this region. The region's high healthcare spending is another important factor driving growth.

Moreover, the U.S. is one of the world's largest respiratory inhaler device markets for medical devices, making it a lucrative pocket for respiratory inhaler device manufacturers. According to SelectUSA, the U.S medical device market accounted for 40% of the global Respiratory Inhaler Devices market in 2018. Favorable healthcare policies, combined with high per capita healthcare spending, have created a favorable environment in the U.S. for the adoption of respiratory inhaler devices. Moreover, the presence of major players such as Merck & Co. is boosting growth in the U.S. These companies' strategies include product launches and expansion plans, which will continue to aid overall expansion in the U.S. Besides, Asia Pacific had a substantial share in the market due to the increased geriatric population, rising awareness of pulmonary diseases, and enhanced healthcare spending in the region.

Competitive Landscape

Major key players in the global respiratory inhalers market are GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca, Propeller Health, Beximco Pharmaceuticals (Beximco Pharma), H&T Presspart, Cohero Health, CHIESI Farmaceutici, Mundipharma, 3M, HELTMAN Medikal, Adherium, Luckys Pharma, Amiko Digital Health, Teva Pharmaceutical Industries, Vectura Group, PULMOTREE MEDICAL GmbH, and Vapo Health.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Respiratory Inhalers Market Snapshot

Chapter 4. Global Respiratory Inhalers Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Key Trends in the Market

4.8. COVID 19 Impact Analysis

4.9. Pelvic Organ Prolapse Incidence and Prevalence in Key Countries

4.10. Stress Urinary Incontinence Incidence and Prevalence in Key Countries

Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

5.2.1. Metered Dosage

5.2.2. Dry Powder Inhaler

Chapter 6. Respiratory Inhalers Market Segmentation 2: By Patients Estimates & Trend Analysis

6.1. By Patients Analysis & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Patients:

6.2.1. Adults

6.2.2. Pediatric

Chapter 7. Respiratory Inhalers Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By End-Users Analysis & Market Share, 2020 & 2030

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

7.2.1. Hospital Pharmacies

7.2.2. Retail

7.2.3. Online

Chapter 8. Respiratory Inhalers Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.1.2. North America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Patients, 2020-2030

8.1.3. North America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.1.4. North America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.2.2. Europe Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Patients, 2020-2030

8.2.3. Europe Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.2.4. Europe Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.3.2. Asia Pacific Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Patients, 2020-2030

8.3.3. Asia Pacific Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.3.4. Asia Pacific Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

8.4.2. Latin America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Patients, (US$ Million) 2020-2030

8.4.3. Latin America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2020-2030

8.4.4. Latin America Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

8.5.2. MEA revenue Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By Patients, (US$ Million) 2020-2030

8.5.3. MEA revenue Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2020-2030

8.5.4. MEA revenue Respiratory Inhalers Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. GlaxoSmithKline

9.2.2. Novartis

9.2.3. Boehringer Ingelheim

9.2.4. Cipla

9.2.5. AstraZeneca

9.2.6. Propeller Health

9.2.7. Beximco Pharmaceuticals (Beximco Pharma)

9.2.8. H&T Presspart

9.2.9. Cohero Health

9.2.10. CHIESI Farmaceutici

9.2.11. Mundipharma

9.2.12. 3M

9.2.13. HELTMAN Medikal

9.2.14. Adherium

9.2.15. Luckys Pharma

9.2.16. Amiko Digital Health

9.2.17. Teva Pharmaceutical Industries

9.2.18. Findair Sp.z.o.o

9.2.19. Vectura Group

8.3. List of Other Prominent Players

Segmentation of Global Respiratory Inhalers Market -

By Products -

  • Metered Dosage
  • Dry Powder Inhaler
  • Nebulizers
  • Compressed Air Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

By Patients -

  • Adults
  • Pediatric

By Technology -

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

By End-Users -

  • Hospital Pharmacies
  • Retail
  • Online

By Region -

North America -

  • The U.S.
  • Canada
  • Mexico

Europe -

  • Germany
  • The U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific -

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America -

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa -

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Respiratory Inhalers Market?

USD 61.29 billion by 2030

CAGR of 6.7% during the forecast period

Our Clients